News | May 24, 2023
Biocon posts Q4 FY23 consolidated PAT at Rs. 313.2 Cr
The company has reported total income of Rs. 3928.8 crores during the period ended March 31, 2023
The company has reported total income of Rs. 3928.8 crores during the period ended March 31, 2023
The approval paves the way for consolidating the company’s position in Kenya and other African markets as part of its global expansion plans
The company has reported total income of Rs. 58.42 crores during the period ended March 31, 2023
This is the second US FDA GMP inspection of this facility within one year
Anuh Pharma has reported total income of Rs. 158.34 crores during the period ended March 31, 2023
Eris Lifesciences has reported total income of Rs. 403.80 crores during the period ended March 31, 2023
Glucon-D, Sugar Free, EverYuth Scrub, Peel Off Face Mask and Nycil maintained their leadership positions in their respective categories as on March 2023
Ephedrine Sulfate Injection USP, 50 mg/mL had annual sales of USD 52 mn in the United States
8th Edition of the event to promote India as a manufacturing hub of quality medical products in the Pharmaceutical and Medical Devices Sector
The company has reported total income of Rs. 1392.72 crores during the period ended March 31, 2023
Subscribe To Our Newsletter & Stay Updated
